TrialInternational journal of radiation oncology, biology, physics2015

Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.

Barbara J Fisher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.